Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oral Contrast Agent market report explains the definition, types, applications, major countries, and major players of the Oral Contrast Agent market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Guerbet (France)
Bayer HealthCare (Germany)
Bracco Imaging (Italy)
JB Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Daiichi Sankyo (Japan)
Magnus Health (India)
GE Healthcare (US)
Taejoon Pharm (South Korea)
Unijules Life Sciences (India)
Jodas (India)
Lantheus (US)
By Type:
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
By End-User:
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Oral Contrast Agent Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Oral Contrast Agent Outlook to 2028- Original Forecasts
-
2.2 Oral Contrast Agent Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Oral Contrast Agent Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Oral Contrast Agent Market- Recent Developments
-
6.1 Oral Contrast Agent Market News and Developments
-
6.2 Oral Contrast Agent Market Deals Landscape
7 Oral Contrast Agent Raw Materials and Cost Structure Analysis
-
7.1 Oral Contrast Agent Key Raw Materials
-
7.2 Oral Contrast Agent Price Trend of Key Raw Materials
-
7.3 Oral Contrast Agent Key Suppliers of Raw Materials
-
7.4 Oral Contrast Agent Market Concentration Rate of Raw Materials
-
7.5 Oral Contrast Agent Cost Structure Analysis
-
7.5.1 Oral Contrast Agent Raw Materials Analysis
-
7.5.2 Oral Contrast Agent Labor Cost Analysis
-
7.5.3 Oral Contrast Agent Manufacturing Expenses Analysis
8 Global Oral Contrast Agent Import and Export Analysis (Top 10 Countries)
-
8.1 Global Oral Contrast Agent Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Oral Contrast Agent Export by Region (Top 10 Countries) (2017-2028)
9 Global Oral Contrast Agent Market Outlook by Types and Applications to 2022
-
9.1 Global Oral Contrast Agent Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Barium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gadolinium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)
-
9.2 Global Oral Contrast Agent Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cardiovascular Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Musculoskeletal Disorders Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Nephrological Disorders Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Oral Contrast Agent Market Analysis and Outlook till 2022
-
10.1 Global Oral Contrast Agent Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Oral Contrast Agent Consumption (2017-2022)
-
10.2.2 Canada Oral Contrast Agent Consumption (2017-2022)
-
10.2.3 Mexico Oral Contrast Agent Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Oral Contrast Agent Consumption (2017-2022)
-
10.3.2 UK Oral Contrast Agent Consumption (2017-2022)
-
10.3.3 Spain Oral Contrast Agent Consumption (2017-2022)
-
10.3.4 Belgium Oral Contrast Agent Consumption (2017-2022)
-
10.3.5 France Oral Contrast Agent Consumption (2017-2022)
-
10.3.6 Italy Oral Contrast Agent Consumption (2017-2022)
-
10.3.7 Denmark Oral Contrast Agent Consumption (2017-2022)
-
10.3.8 Finland Oral Contrast Agent Consumption (2017-2022)
-
10.3.9 Norway Oral Contrast Agent Consumption (2017-2022)
-
10.3.10 Sweden Oral Contrast Agent Consumption (2017-2022)
-
10.3.11 Poland Oral Contrast Agent Consumption (2017-2022)
-
10.3.12 Russia Oral Contrast Agent Consumption (2017-2022)
-
10.3.13 Turkey Oral Contrast Agent Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Oral Contrast Agent Consumption (2017-2022)
-
10.4.2 Japan Oral Contrast Agent Consumption (2017-2022)
-
10.4.3 India Oral Contrast Agent Consumption (2017-2022)
-
10.4.4 South Korea Oral Contrast Agent Consumption (2017-2022)
-
10.4.5 Pakistan Oral Contrast Agent Consumption (2017-2022)
-
10.4.6 Bangladesh Oral Contrast Agent Consumption (2017-2022)
-
10.4.7 Indonesia Oral Contrast Agent Consumption (2017-2022)
-
10.4.8 Thailand Oral Contrast Agent Consumption (2017-2022)
-
10.4.9 Singapore Oral Contrast Agent Consumption (2017-2022)
-
10.4.10 Malaysia Oral Contrast Agent Consumption (2017-2022)
-
10.4.11 Philippines Oral Contrast Agent Consumption (2017-2022)
-
10.4.12 Vietnam Oral Contrast Agent Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Oral Contrast Agent Consumption (2017-2022)
-
10.5.2 Colombia Oral Contrast Agent Consumption (2017-2022)
-
10.5.3 Chile Oral Contrast Agent Consumption (2017-2022)
-
10.5.4 Argentina Oral Contrast Agent Consumption (2017-2022)
-
10.5.5 Venezuela Oral Contrast Agent Consumption (2017-2022)
-
10.5.6 Peru Oral Contrast Agent Consumption (2017-2022)
-
10.5.7 Puerto Rico Oral Contrast Agent Consumption (2017-2022)
-
10.5.8 Ecuador Oral Contrast Agent Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Oral Contrast Agent Consumption (2017-2022)
-
10.6.2 Kuwait Oral Contrast Agent Consumption (2017-2022)
-
10.6.3 Oman Oral Contrast Agent Consumption (2017-2022)
-
10.6.4 Qatar Oral Contrast Agent Consumption (2017-2022)
-
10.6.5 Saudi Arabia Oral Contrast Agent Consumption (2017-2022)
-
10.6.6 United Arab Emirates Oral Contrast Agent Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Oral Contrast Agent Consumption (2017-2022)
-
10.7.2 South Africa Oral Contrast Agent Consumption (2017-2022)
-
10.7.3 Egypt Oral Contrast Agent Consumption (2017-2022)
-
10.7.4 Algeria Oral Contrast Agent Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Oral Contrast Agent Consumption (2017-2022)
-
10.8.2 New Zealand Oral Contrast Agent Consumption (2017-2022)
11 Global Oral Contrast Agent Competitive Analysis
-
11.1 Guerbet (France)
-
11.1.1 Guerbet (France) Company Details
-
11.1.2 Guerbet (France) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Guerbet (France) Oral Contrast Agent Main Business and Markets Served
-
11.1.4 Guerbet (France) Oral Contrast Agent Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bayer HealthCare (Germany)
-
11.2.1 Bayer HealthCare (Germany) Company Details
-
11.2.2 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bayer HealthCare (Germany) Oral Contrast Agent Main Business and Markets Served
-
11.2.4 Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Bracco Imaging (Italy)
-
11.3.1 Bracco Imaging (Italy) Company Details
-
11.3.2 Bracco Imaging (Italy) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Bracco Imaging (Italy) Oral Contrast Agent Main Business and Markets Served
-
11.3.4 Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 JB Chemicals and Pharmaceuticals (India)
-
11.4.1 JB Chemicals and Pharmaceuticals (India) Company Details
-
11.4.2 JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Main Business and Markets Served
-
11.4.4 JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Spago Nanomedicine (Sweden)
-
11.5.1 Spago Nanomedicine (Sweden) Company Details
-
11.5.2 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Main Business and Markets Served
-
11.5.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Daiichi Sankyo (Japan)
-
11.6.1 Daiichi Sankyo (Japan) Company Details
-
11.6.2 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Main Business and Markets Served
-
11.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Magnus Health (India)
-
11.7.1 Magnus Health (India) Company Details
-
11.7.2 Magnus Health (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Magnus Health (India) Oral Contrast Agent Main Business and Markets Served
-
11.7.4 Magnus Health (India) Oral Contrast Agent Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 GE Healthcare (US)
-
11.8.1 GE Healthcare (US) Company Details
-
11.8.2 GE Healthcare (US) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 GE Healthcare (US) Oral Contrast Agent Main Business and Markets Served
-
11.8.4 GE Healthcare (US) Oral Contrast Agent Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Taejoon Pharm (South Korea)
-
11.9.1 Taejoon Pharm (South Korea) Company Details
-
11.9.2 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Taejoon Pharm (South Korea) Oral Contrast Agent Main Business and Markets Served
-
11.9.4 Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Unijules Life Sciences (India)
-
11.10.1 Unijules Life Sciences (India) Company Details
-
11.10.2 Unijules Life Sciences (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Unijules Life Sciences (India) Oral Contrast Agent Main Business and Markets Served
-
11.10.4 Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Jodas (India)
-
11.11.1 Jodas (India) Company Details
-
11.11.2 Jodas (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Jodas (India) Oral Contrast Agent Main Business and Markets Served
-
11.11.4 Jodas (India) Oral Contrast Agent Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Lantheus (US)
-
11.12.1 Lantheus (US) Company Details
-
11.12.2 Lantheus (US) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Lantheus (US) Oral Contrast Agent Main Business and Markets Served
-
11.12.4 Lantheus (US) Oral Contrast Agent Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Oral Contrast Agent Market Outlook by Types and Applications to 2028
-
12.1 Global Oral Contrast Agent Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Barium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Gadolinium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Oral Contrast Agent Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Cardiovascular Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Musculoskeletal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Nephrological Disorders Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Oral Contrast Agent Market Analysis and Outlook to 2028
-
13.1 Global Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.2.2 Canada Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.2.3 Mexico Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.2 UK Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.3 Spain Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.4 Belgium Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.5 France Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.6 Italy Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.7 Denmark Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.8 Finland Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.9 Norway Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.10 Sweden Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.11 Poland Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.12 Russia Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.3.13 Turkey Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.2 Japan Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.3 India Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.4 South Korea Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.8 Thailand Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.9 Singapore Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.11 Philippines Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.5.2 Colombia Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.5.3 Chile Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.5.4 Argentina Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.5.6 Peru Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.6.3 Oman Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.6.4 Qatar Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.7.2 South Africa Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.7.3 Egypt Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.7.4 Algeria Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Oral Contrast Agent Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Oral Contrast Agent Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Oral Contrast Agent
-
Figure of Oral Contrast Agent Picture
-
Table Global Oral Contrast Agent Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Oral Contrast Agent Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Barium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Gadolinium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Musculoskeletal Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Nephrological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Contrast Agent Consumption by Country (2017-2022)
-
Table North America Oral Contrast Agent Consumption by Country (2017-2022)
-
Figure United States Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Canada Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Mexico Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table Europe Oral Contrast Agent Consumption by Country (2017-2022)
-
Figure Germany Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure UK Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Spain Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Belgium Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure France Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Italy Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Denmark Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Finland Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Norway Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Sweden Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Poland Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Russia Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Turkey Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table APAC Oral Contrast Agent Consumption by Country (2017-2022)
-
Figure China Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Japan Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure India Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Thailand Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Singapore Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Philippines Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table South America Oral Contrast Agent Consumption by Country (2017-2022)
-
Figure Brazil Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Colombia Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Chile Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Argentina Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Peru Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table GCC Oral Contrast Agent Consumption by Country (2017-2022)
-
Figure Bahrain Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Oman Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Qatar Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table Africa Oral Contrast Agent Consumption by Country (2017-2022)
-
Figure Nigeria Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure South Africa Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Egypt Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Algeria Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table Oceania Oral Contrast Agent Consumption by Country (2017-2022)
-
Figure Australia Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Oral Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table Guerbet (France) Company Details
-
Table Guerbet (France) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guerbet (France) Oral Contrast Agent Main Business and Markets Served
-
Table Guerbet (France) Oral Contrast Agent Product Portfolio
-
Table Bayer HealthCare (Germany) Company Details
-
Table Bayer HealthCare (Germany) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare (Germany) Oral Contrast Agent Main Business and Markets Served
-
Table Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio
-
Table Bracco Imaging (Italy) Company Details
-
Table Bracco Imaging (Italy) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging (Italy) Oral Contrast Agent Main Business and Markets Served
-
Table Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio
-
Table JB Chemicals and Pharmaceuticals (India) Company Details
-
Table JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Main Business and Markets Served
-
Table JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio
-
Table Spago Nanomedicine (Sweden) Company Details
-
Table Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spago Nanomedicine (Sweden) Oral Contrast Agent Main Business and Markets Served
-
Table Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio
-
Table Daiichi Sankyo (Japan) Company Details
-
Table Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo (Japan) Oral Contrast Agent Main Business and Markets Served
-
Table Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio
-
Table Magnus Health (India) Company Details
-
Table Magnus Health (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Magnus Health (India) Oral Contrast Agent Main Business and Markets Served
-
Table Magnus Health (India) Oral Contrast Agent Product Portfolio
-
Table GE Healthcare (US) Company Details
-
Table GE Healthcare (US) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare (US) Oral Contrast Agent Main Business and Markets Served
-
Table GE Healthcare (US) Oral Contrast Agent Product Portfolio
-
Table Taejoon Pharm (South Korea) Company Details
-
Table Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Taejoon Pharm (South Korea) Oral Contrast Agent Main Business and Markets Served
-
Table Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio
-
Table Unijules Life Sciences (India) Company Details
-
Table Unijules Life Sciences (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Unijules Life Sciences (India) Oral Contrast Agent Main Business and Markets Served
-
Table Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio
-
Table Jodas (India) Company Details
-
Table Jodas (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jodas (India) Oral Contrast Agent Main Business and Markets Served
-
Table Jodas (India) Oral Contrast Agent Product Portfolio
-
Table Lantheus (US) Company Details
-
Table Lantheus (US) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus (US) Oral Contrast Agent Main Business and Markets Served
-
Table Lantheus (US) Oral Contrast Agent Product Portfolio
-
Figure Global Barium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gadolinium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Musculoskeletal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nephrological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Contrast Agent Consumption Forecast by Country (2022-2028)
-
Table North America Oral Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure United States Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oral Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Germany Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Oral Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure China Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Oral Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Brazil Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Oral Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Oral Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Oral Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Australia Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
